Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

METROPLEX ADVENTIST HOSPITAL INC

NPI: 1629089966 · KILLEEN, TX 76549 · Ambulatory Surgical Clinic/Center · NPI assigned 08/11/2006

$10.08M
Total Medicaid Paid
146,558
Total Claims
134,621
Beneficiaries
90
Codes Billed
2018-07
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGARCIA, JANET (CFO)
NPI Enumeration Date08/11/2006

Related Entities

Other providers sharing the same authorized official: GARCIA, JANET

ProviderCityStateTotal Paid
METROPLEX ADVENTIST HOSPITAL INC LAMPASAS TX $1.22M
EDUARDO RAMOS MD PLLC LAS VEGAS NV $77K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 81 $5K
2020 3,135 $244K
2021 44,551 $2.64M
2022 38,542 $2.75M
2023 40,069 $2.97M
2024 20,180 $1.48M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 14,545 13,628 $4.65M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 4,960 4,515 $1.97M
99283 Emergency department visit for the evaluation and management, moderate severity 22,988 21,844 $1.09M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 6,560 6,070 $612K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,484 3,382 $162K
71045 Radiologic examination, chest; single view 5,794 5,282 $159K
0225U 2,542 2,475 $149K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 5,304 4,707 $135K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,419 1,378 $131K
80053 Comprehensive metabolic panel 11,424 10,350 $126K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 14,680 13,251 $115K
41899 Unlisted procedure, dentoalveolar structures 75 74 $91K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,866 1,782 $82K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 343 326 $66K
42820 Tonsillectomy and adenoidectomy; younger than age 12 17 16 $54K
96375 Therapeutic injection; each additional sequential IV push 1,693 1,546 $51K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,796 3,468 $51K
81001 13,057 12,131 $40K
81025 3,134 2,986 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,601 1,457 $28K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 543 476 $25K
84484 3,145 1,928 $21K
96361 Intravenous infusion, hydration; each additional hour 954 888 $21K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 523 500 $16K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 522 501 $15K
87086 Culture, bacterial; quantitative colony count, urine 2,056 1,940 $15K
80048 Basic metabolic panel (calcium, ionized) 1,843 1,700 $14K
84703 2,154 1,990 $13K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 134 133 $13K
76801 127 119 $12K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 118 117 $10K
74177 Computed tomography, abdomen and pelvis; with contrast material 209 200 $10K
93976 209 196 $10K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 22 13 $8K
84702 749 656 $7K
70450 Computed tomography, head or brain; without contrast material 186 182 $6K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 33 31 $6K
83690 1,645 1,535 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,261 2,044 $5K
86780 247 230 $4K
J7030 Infusion, normal saline solution , 1000 cc 1,806 1,624 $4K
86703 190 177 $4K
80074 54 54 $3K
87529 74 35 $3K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 57 56 $3K
82077 252 204 $3K
76830 Ultrasound, transvaginal 25 25 $2K
86850 120 116 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,660 1,517 $2K
J7050 Infusion, normal saline solution, 250 cc 408 327 $2K
86900 565 533 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 383 362 $1K
86901 564 532 $1K
80179 108 91 $1K
0002A 68 68 $1K
80143 94 77 $1K
0001A 82 81 $1K
86762 52 51 $990.28
86694 48 48 $962.24
86787 55 54 $938.26
0012A 32 32 $922.04
0011A 30 30 $890.78
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 57 56 $775.30
84443 Thyroid stimulating hormone (TSH) 91 80 $679.57
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 12 12 $652.61
83605 231 197 $596.12
82950 90 87 $590.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg 195 184 $563.07
J2270 Injection, morphine sulfate, up to 10 mg 365 323 $377.15
85660 56 54 $374.66
36415 Collection of venous blood by venipuncture 382 333 $319.21
J7120 Ringers lactate infusion, up to 1000 cc 215 194 $296.94
87210 55 55 $253.68
71046 Radiologic examination, chest; 2 views 24 24 $249.20
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 13 13 $244.57
87481 45 44 $235.84
82947 281 181 $173.28
85027 92 84 $169.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 42 25 $117.39
87077 135 98 $81.92
83880 13 13 $65.96
87186 92 68 $51.36
85610 28 27 $50.40
85007 39 37 $49.01
J1200 Injection, diphenhydramine hcl, up to 50 mg 90 83 $47.31
J3010 Injection, fentanyl citrate, 0.1 mg 17 14 $29.65
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 15 15 $25.83
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 69 66 $19.22
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 16 12 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 109 101 $0.00